Table 1. Six hypothetical laboratories and their metered dose inhaler-associated carbon footprint and medication cost, per 100 BDR tests.
A | B | C | D | E | F | |
Laboratory practice | ||||||
Actuations per BDR test | 2 | 4 | 4 | 12 | 4 | 4 |
Reuse of MDIs | Yes | Yes | Yes | Yes | No | No |
Disposal | Incineration | Incineration | Landfill | Landfill | Incineration | Landfill |
Consumption (per 100 BDR tests) | ||||||
MDIs | 1 | 2 | 2 | 6 | 100 | 100 |
Actuations | 200 | 400 | 400 | 1200 | 400 | 400 |
Medication cost (per 100 BDR tests) | ||||||
$A | $A6.5 | $A13 | $A13 | $A39 | $A650 | $A650 |
Carbon footprint in kg CO2e (per 100 BDR tests) | ||||||
Manufacture | 1 | 2 | 2 | 6 | 100 | 100 |
Patient use | 25.3 | 50.7 | 50.7 | 152 | 50.7 | 50.7 |
Disposal (propellant) | <0.001 | <0.001 | 2.66 | 7.98 | 0.26 | 2607 |
Disposal (other) | 0.015 | 0.030 | 0 | 0 | 2.9 | 0 |
Total kg, CO2e | 26.3 | 52.7 | 55.4 | 166 | 154 | 2758 |
The colours in the above table indicate the carbon footprint associated with that particular laboratory practice. Actions with the lowest carbon footprint have green shading, actions with the highest carbon footprint have red shading, while orange indicates an intermediate carbon footprint.
$A, Australian dollars; BDR, bronchodilator responsiveness; CO2e, carbon dioxide equivalent; MDI, metered dose inhaler